epoetin alfa

Trials studying epoetin alfa

• phase3Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japancompletedn=323
• phase3Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japancompletedn=304
• phase3ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusionsrecruitingn=360
• phase3A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusionsrecruitingn=300
• phase3A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)not yet recruitingn=100
• phase2Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESAactive not recruitingn=13
• phase3A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.completedn=233
• phase1Clinical Trial of Efepoetin Alfa in Healthy Subjectscompletedn=40